Related Experiment Video
Updated: Jul 14, 2026
06:39
Curcuminoid-Mediated Antimicrobial Photodynamic Therapy on a Murine Model of Oral Candidiasis
Published on: October 27, 2023
Immunomodulation by curcumin
Subhash C Gautam1, Xiaohua Gao, Scott Dulchavsky
1Department of Surgery, Henry Ford Health System, Detroit, MI 48202, USA. sgautam1@hfhs.org
Advances in Experimental Medicine and Biology
|June 16, 2007
Summary
Curcumin, derived from turmeric, shows promise in modulating immune responses. This review explores its effects on immune cells, antigen presentation, and both humoral and cell-mediated immunity.
Area of Science:
- Immunology
- Pharmacology
- Natural Products
Background:
- Turmeric (Curcuma longa) has a long history in traditional medicine.
- Curcumin, the active compound in turmeric, possesses anti-inflammatory and antioxidant properties.
- Emerging research suggests curcumin's potential in cancer and inflammatory disease treatment.
Purpose of the Study:
- To review the current understanding of curcumin's immunomodulatory effects.
- To explore curcumin's impact on various components of the immune system.
- To highlight the need for further research into curcumin's role in immune response development.
Main Methods:
- Literature review of existing studies on curcumin and immunity.
- Analysis of research on curcumin's effects on lymphoid cells and antigen presentation.
- Examination of studies investigating curcumin's influence on humoral and cell-mediated immunity.
Main Results:
- Curcumin influences lymphoid cell populations and antigen presentation.
- Evidence suggests curcumin modulates both humoral and cell-mediated immune responses.
- Curcumin affects cytokine production, impacting immune signaling.
Conclusions:
- Curcumin exhibits significant immunomodulatory properties.
- Further investigation into curcumin's mechanisms of action on the immune system is warranted.
- Curcumin holds potential for therapeutic applications in immune-related conditions.
Related Concept Videos
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:28Inflammatory Response
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...